SCHEMBL2348309

SCHEMBL2348309

CC(C)(C)c1ccc(-n2c(N3CCNCC3)cc3ccccc32)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR3A P46098 5/20 0.44
▸ HTR3E A5X5Y0 4/20 0.44
▸ HTR3B O95264 4/20 0.44
▸ HTR3D Q70Z44 4/20 0.44
▸ HTR3C Q8WXA8 4/20 0.44
▸ SIGMAR1 Q99720 4/20 0.44
▸ HTR5A P47898 2/20 0.44
▸ HTR1A P08908 3/20 0.43
▸ HRH4 Q9H3N8 1/20 0.39
▸ HRH3 Q9Y5N1 1/20 0.39
▸ KDR P35968 1/20 0.39
▸ HTR2C P28335 4/20 0.39
▸ HTR2A P28223 3/20 0.39
▸ HPGD P15428 1/20 0.37
▸ ADRB1 P08588 5/20 0.37
▸ HTR1D P28221 3/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ PRKCI P41743 1/20 0.36
▸ NCF1 P14598 2/20 0.36
▸ HTR1B P28222 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12451405 0.87 HPGD (0.37) SIGMAR1HPGDALDH1A1HTR6TSHR
SCHEMBL11555106 0.85 HTR3E (0.53) HTR3AHTR3EHTR3BHTR3DHTR3C
SCHEMBL2346369 0.83 ADRB1 (0.53) HTR3AHTR3EHTR3BHTR3DHTR3C
SCHEMBL2345082 0.83 HTR3E (0.48) HTR3AHTR3EHTR3BHTR3DHTR3C
SCHEMBL2342043 0.82 HTR3A (0.56) HTR3AHTR3EHTR3BHTR3DHTR3C
SCHEMBL2346242 0.78 ADRB1 (0.60) HTR3AHTR3EHTR3BHTR3DHTR3C
SCHEMBL2348220 0.76 ADRB1 (0.62) HTR3AHTR3EHTR3BHTR3DHTR3C
SCHEMBL2345155 0.75 HTR1A (0.44) HTR3AHTR3EHTR3BHTR3DHTR3C
SCHEMBL2343308 0.75 SOS1 (0.47) HTR3AHTR3EHTR3BHTR3DHTR3C
SCHEMBL270283 0.74 ADRB1 (0.62) HTR3AHTR3EHTR3BHTR3DHTR3C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8008491-B2 poly(adenosine 5'-diphosphate ribose) polymerase inhibitors such as 1-phenyl-2-(piperazin-1-yl)-1,3-dihydropyrrolo[2,3-b]pyridine-3-carboxaldehyde, used in the treatment and/or prevention central nervous system and cardiovascular disorders AVENTIS PHARMACEUTICALS, INC. (US) 2011-08-30 — — US disclosed
Send feedback